Related Experiment Video
Updated: May 5, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
A Comprehensive Review of Percutaneous and Surgical Left Atrial Appendage Occlusion
Michał Święczkowski1, Emil Julian Dąbrowski1, Paweł Muszyński1
1Department of Invasive Cardiology, Medical University of Bialystok, 24A Sklodowskiej-Curie St., 15-276 Bialystok, Poland.
Insights
Left atrial appendage occlusion (LAAO) offers a safe alternative to anticoagulants for preventing strokes in atrial fibrillation (AF) patients. Both surgical and percutaneous LAAO show favorable outcomes, with ongoing research to improve techniques and patient care.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Procedures
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia linked to high thromboembolic risk.
- Anticoagulant therapy is standard but carries bleeding risks and contraindications.
- Left atrial appendage occlusion (LAAO) provides an alternative stroke prevention strategy.
Purpose of the Study:
- To review current evidence on surgical and percutaneous LAAO.
- To discuss indications, technical advancements, and imaging in LAAO.
- To highlight future research directions for LAAO.
Main Methods:
- Systematic review of randomized clinical trials and meta-analyses.
- Analysis of preprocedural planning using various imaging modalities.
- Evaluation of postprocedural management and surveillance strategies.
Main Results:
- Both percutaneous and surgical LAAO demonstrate favorable clinical outcomes.
- Imaging techniques are crucial for preprocedural planning and postprocedural surveillance.
- Personalized anticoagulation and device monitoring are key post-procedure.
Conclusions:
- LAAO is an effective option for preventing AF-related thromboembolic events.
- Further research is needed to optimize antithrombotic regimens and procedural aspects.
- Refining LAAO techniques and improving patient outcomes remain key goals.
Abstract:
Atrial fibrillation (AF) is the most common arrhythmia worldwide, and is associated with a significant risk of thromboembolic events. Left atrial appendage occlusion (LAAO) has emerged as a promising alternative for patients with contraindications or intolerance to anticoagulant therapy. This review summarises the current evidence, indications, and technical advancements in surgical and percutaneous LAAO. Preprocedural planning relies on various imaging techniques, each with unique advantages and limitations. The existing randomised clinical trials and meta-analyses demonstrate favourable results for both percutaneous and surgical LAAO. Postprocedural management emphasises personalised anticoagulation strategies and comprehensive imaging surveillance to ensure device stability and detect complications. Future focus should be put on antithrombotic regimens, investigating predictors of device-related complications, and simplifying procedural aspects to enhance patient outcomes. In summary, LAAO is presented as a valuable therapeutic option for preventing AF-related thromboembolic events, with ongoing research aimed at refining techniques and improving patient care.
